OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion

Health services Manufacturing

United Kingdom

Japan

Secondary

14 July 2025

Share:

OrganOx (company)

United Kingdom

Health services Manufacturing

Total investments received (USD): N/A

Round value (USD): 2.03b

Round investors: Terumo Corporation

Company: OrganOx

Industry: Health services Manufacturing

Related deals

Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Health services Manufacturing Pharma

United Kingdom

France

Sweden

United States

Netherlands

Switzerland

Investments 07 November 2025

Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.

Biotech Health services Manufacturing

United Kingdom

France

Israel

United States

Investments 07 June 2025

CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.

Biotech Health services Manufacturing

United Kingdom

Netherlands

United States

Investments 09 May 2025

OrganOx completed a $142 million primary and secondary equity financing led by HealthQuest Capital, joined by BGF and Lauxera Capital Partners

Health services Manufacturing

United Kingdom

France

Belgium

United States

Investments 14 February 2025